Jay-Z’s full “Moonlight” short film has made its way from TIDAL to VEVO, which should excite fans of the rapper’s music, and of free stuff.The seven-and-a-half-minute movie, directed by “Master of None” alum Alan Yang, reimagines the classic NBC sitcom “Friends” with an all-black cast.
NYS Entity Status
NYS Filing Date
SEPTEMBER 18, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2014 - MOVIES IN THE MOONLIGHT CCP INC
Around the Web
- Watch Jay-Z’s Full ‘Moonlight’ Short Film – Yes, the Black ‘Friends’ One (Video)
By Tony Maglio, provided by
- Friday Aug 11, 2017
- An Appraisal: For Jerry Lewis, Few Statuettes but Lots of Influence
By NEIL GENZLINGER - Sunday Aug 20, 2017
The comic and filmmaker, who died Sunday, may not have collected many showbiz laurels, but his work shaped the comedians who came along after him.
- Oscar Winner Mahershala Ali Could Be The Next Star Of ‘True Detective’
By Alyssa Fikse - Friday Jun 30, 2017
Mahershala Ali could be following up his Oscar win for 'Moonlight' with the lead in 'True Detective' season three.
- OWN Orders Drama Series From ‘Moonlight’ Writer Tarell Alvin McCraney
By Reid Nakamura, provided by
- Wednesday Aug 16, 2017
Haunted by the death of his closest friend, and relied on by his hardworking mother to find a way out of poverty, a 14-year-old prodigy from the projects must choose between the streets that raised him or the higher education that may offer him a way out.McCraney, whose unpublished play served as the basis for Barry Jenkins’ Oscar-winning 2016 movie, will write and executive produce the series.“I wanted to explore the pivotal steps towards adulthood and identity, the ones we take when we think or feel we have no other choice,” McCraney said in a statement.
- Cancer drug research moving fast in immunotherapy field
By Michelle Fay Cortez - Tuesday Sep 5, 2017
The last few weeks have been historic in the fight against cancer. Novartis got approval for the first treatment in a revolutionary new class of drugs, shortly after Gilead Sciences Inc. spent $11.9 billion on a biotech company working in the field. Neither can rest on its laurels. Research in the field is moving so fast that today’s breakthroughs can easily become tomorrow’s has-beens. “I can’t think of any other therapies in oncology that have seen such rapid development,” said Rachel Webster, senior director of oncology at Decision Resources Group, a health care research and consulting firm in London.
- State of the Art: The Frightful Five Want to Rule Entertainment. They Are Hitting Limits.
By FARHAD MANJOO - Wednesday Oct 11, 2017
Apple, Google and other tech giants are pushing deeper into cultural industries — and stumbling in ways that suggest a certain cluelessness.